Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
The complicated world of compounded weight-loss drugs
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The minute-long spot begins by skewering the American health care system, saying it's "designed to keep us sick and stuck" while profiting off of America's obesity epidemic.
Hosted on MSN3d
Big Pharma’s Worst Nightmare or a Total Ripoff? The Truth About Hims’ Cheap Weight Loss PlansHims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Men can schedule a consultation via Hims and then receive a prescription for Metformin, Topiramate, or a compounded weight loss formula featuring multiple drugs in one. Hims’ weight ...
Ahead of the Super Bowl, telehealth company Hims & Hers on Jan. 28 released ... side effect information” about the compounded weight loss drugs that it promotes. And they say that they ...
A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ lobbying group, which says it’s “misleading” and potentially ...
The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about risks. By Dani Blum The first thing the ad shows is a scale. Over the ...
said in a letter to the FDA the ad risks misleading patients because it omits information about the drugs safety and side effects. Hims & Hers, which markets weight loss and other medications ...
A Super Bowl ad on weight loss drugs from Hims & Hers has caught the attention of Congress. Sen. Dick Durbin (D-Ill.) and Sen. Dr. Roger Marshall (R-Kan.) sent a letter to Food and Drug ...
selling weight-loss drugs to both women and men. The ad also marks a pivot for the telehealth company colloquially known as Hims, which rose to prominence just under a decade ago, slickly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback